PKS's Principal Activity is the provision of software services to the healthcare industry.
|Bid / Ask||-|
|Volume (4w avg)|
|vs Sector (1yr)||+117.37%|
|vs ASX 200 (1yr)||+99.08%|
|ASX Rank||967 of 2,319|
|Sector Rank||84 of 198|
PKS Holdings Limited (PKS) is a healthcare technology company which provides a proprietary subscription based Clinical Decision Support (CDS) system called "RippleDown". RippleDown automates the human decision-making process in healthcare organisations and has two components that address a number of the key issues faced by healthcare organisations: RippleDown Auditor and RippleDown Expert. PKS Holdings Limited is based in Sydney, Australia.
No incorporation details available.
DPS and Yield calculations use the Pay Date.
|Ms Belinda Ann Cleminson||Company Secretary||Apr 2021|
|Mr Jim Birch||Non-Executive Director||Mar 2021||
Mr Jim Birch
Mr Birch has more than 30 years' experience in implementing technological change in the healthcare industry, having previously served as Chair of the Australian Digital Health Agency, Deputy Chair of the Independent Hospital Pricing Authority, CEO of the SA Department of Health, and global healthcare leader for consulting firm EY. He is currently Chair of the Little Company of Mary Health Care (Calvary), the Australian Red Cross Blood Service (now known as Lifeblood), the SA Women's and Children's Health Network and Clevertar Pty Ltd.
|Mr Timothy Kelsey||Chief Executive Officer||Oct 2020|
|Mr Stephen Frederick Borness||Non-Executive Director||Jun 2020||
Mr Stephen Frederick Borness
Mr Borness has founded and directed strategy for several technology and health related private companies, and was Board Chair and Finance Director of Pavilion Health before it merged with PKS. He has led projects and has expertise in im-plementation of digital technologies, health system analytics and cybersecurity. Prior to focusing on the health and technology sectors Mr Borness worked as an investment banker across the Australian, European and U.S. markets.
|Mr Brad Lancken||Non-Executive Director||Oct 2019||
Mr Brad Lancken
Mr Lancken is an experienced private and public company executive with over 15 years experience and is a Managing Partner of Liverpool Partners with former roles at Archer Capital and Seven Group Holdings Limited. Brad has global experience in the technology and SaaS sector including former roles on the advisory board of China Media Capital Partners and as a Board Director of Onesource Group. iseekplant.com.au and Found Careers. He also has domestic health care experience having led investments in the aged care sector, currently a Director of residential aged care provider CraigCare and serves the community as a Director of the NSW Institute of Sport.
|Mr Paul Williams||Non-Executive Director||May 2019||
Mr Paul Williams
Mr Williams has a proven history of ICT managerial performance across the health, transport, logistics and resources industries, most recently as Chief Information Officer at Healthscope Ltd where he was responsible for all ICT activities at Australia's largest provider of integrated healthcare, covering 44 private hospitals across Australia, national and international pathology services and 50 medical centres. He has experience in delivering innovation, change and reform within large and complex businesses. Prior to Healthscope, Paul was the Head of Information Services at the National E-Health Transition Authority and National IT Manager, Pathology for Mayne/Symbion/Primary. He is chairperson of Risk Committee.
|Mr Andrew Gray||Non-Executive Director||May 2019||
Mr Andrew Gray
Mr Gray is a Managing Director of Potentia, a technology-focused private equity investment firm. Before founding Potentia, Andrew was a Managing Director at Archer Capital, an Australian based private equity firm with more than $3 billion in capital under management. While at Archer Capital, Andrew led the firm's largest investment into software business MYOB (its largest ever return to inves-tors). Before joining Archer Capital, Andrew was a partner with Francisco Partners, a technology-focused global private equity firm with over US$10 billion in capital under management. Andrew serves as Chairman of Ascender HCM, a leading payroll software provider and Chairman of Linkly, a provider of payments integra-tion software. He is also a Director of Micromine, a general mine planning soft-ware business, PKS, a listed healthcare software business. He was former Non-Executive Director of LiveTiles Limited.
|Mr Michael (Mike) Hastings Hill||Non-Executive Chairman,Non-Executive Director||Jun 2018||
Mr Michael (Mike) Hastings Hill
Non-Executive Chairman,Non-Executive Director
Mr Hill was Partner of Ernst & Young, Mike has been involved in working with management teams and boards across a number of companies and industries for more than 20 years. He is the MD, Co-CIO and Founder of the Bombora Special Investments Fund. Prior to Bombora he was an Investment Partner with Ironbridge, a private equity investment fund which invested $1.5bn. Mike has served as Chairman of multiple ASX-listed companies over the past six years. Other current directorships includes AHAlife Holdings Limited (Non-Executive Chairman) and Janison Education Group Limited (Chairman). Former directorships includes Rhipe Limited (Non-Executive Chairman) resigned on 26 March 2019, LiveTiles Limited (Non-Executive Director) resigned on 5 September 2017, JustKapital Litigation Partners Limited (Non-Executive Director) resigned on 27 November 2017, Acrow Formwork and Construction Limited (Non-Executive Director) resigned on 19 43709
PKS directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
|23/04/21||Stephen Borness||Issued||1,342,857||$0.35||$469,999||Issue of securities|
|23/04/21||Andrew Gray||Issued||5,000,000||$0.35||$1,750,000||Issue of securities|
|04/09/20||Stephen Borness||Buy||+250,000||$0.25||$62,500||On-market trade|
|10/06/20||Brad Lancken||Issued||1,000,000||$0.175||$175,000||Director remuneration|
|10/06/20||Brad Lancken||Issued||375,000||$0.175||$65,625||Director remuneration|
|20/05/20||Michael (Mike) Hill||Buy||+117,000||$0.17||$19,890||On-market trade|
The current holdings of PKS directors.
|Director||Last Notice||Direct Shares||Indirect Shares||Options||Convertibles|
|Michael (Mike) Hill||30/06/2020||N/A||1,367,000||N/A||N/A|
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
|Name||Last Notice||Total Shares||Shares Held (%)|
|Mirrabooka Investments Limited||26/02/2021||9,673,818||5.16|
|Bombora Investment Management Pty Limited||26/02/2021||18,600,000||8.63|
12 month transaction history compiled from ASX announcements.
|Date||Name||Bought||Previous %||New %|
|26-02-21||Bombora Investment Management Pty Limited||6,015,000||10.39||8.63|
|26-02-21||Mirrabooka Investments Limited||9,673,818||--||5.16|
12 month transaction history compiled from ASX announcements.
|Date||Name||Sold||Previous %||New %|
|01-03-21||Celerity Investments Pty Limited||9,705,127||5.21||--|
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.